{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:30:59Z","timestamp":1790040659269,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","award":["5 T32 CA101642 02"],"award-info":[{"award-number":["5 T32 CA101642 02"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014487","name":"Clovis Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014487","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["5P50CA098258-13"],"award-info":[{"award-number":["5P50CA098258-13"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018096","name":"GOG Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ajog.2020.08.032","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T21:05:33Z","timestamp":1597439133000},"page":"191.e1-191.e15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":114,"title":["Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer"],"prefix":"10.1016","volume":"224","author":[{"given":"Shannon N.","family":"Westin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Fellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte C.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell R.","family":"Broaddus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misty L.","family":"Woodall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navdeep","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana L.","family":"Urbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois M.","family":"Ramondetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Schmeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela T.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole D.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K.","family":"Burzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpa M.","family":"Nick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Milbourne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen H.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane C.","family":"Bodurka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9450-5517","authenticated-orcid":false,"given":"Melinda S.","family":"Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2020.08.032_bib1","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajog.2020.08.032_bib2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behavior of endometrial hyperplasia. A long-term study of \u201cuntreated\u201d hyperplasia in 170 patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2020.08.032_bib3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ygyno.2014.05.018","article-title":"Endometrial cancer: a review and current management strategies: part I","volume":"134","author":"Burke","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2020.08.032_bib4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.AOG.0000154151.14516.f7","article-title":"Risk factors for young premenopausal women with endometrial cancer","volume":"105","author":"Soliman","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.032_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40661-016-0023-8","article-title":"Surgical safety and personal costs in morbidly obese, multimorbid patients diagnosed with early-stage endometrial cancer having a hysterectomy","volume":"3","author":"Obermair","year":"2016","journal-title":"Gynecol Oncol Res Pract"},{"key":"10.1016\/j.ajog.2020.08.032_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ygyno.2014.01.041","article-title":"The impact of obesity on surgical staging, complications, and survival with uterine cancer: a Gynecologic Oncology Group LAP2 ancillary data study","volume":"133","author":"Gunderson","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2020.08.032_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ygyno.2004.06.045","article-title":"Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review","volume":"95","author":"Ramirez","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2020.08.032_bib8","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.15585\/mmwr.mm6748a1","article-title":"Uterine cancer incidence and mortality-United States, 1999\u20132016","volume":"67","author":"Henley","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajog.2020.08.032_bib9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ygyno.2012.01.003","article-title":"Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review","volume":"125","author":"Gunderson","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2020.08.032_bib10","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0029-7844(97)00297-4","article-title":"Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40","volume":"90","author":"Randall","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.032_bib11","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1200\/JCO.1999.17.6.1736","article-title":"Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group","volume":"17","author":"Thigpen","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2020.08.032_bib12","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/annonc\/mdq463","article-title":"Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women","volume":"22","author":"Minig","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ajog.2020.08.032_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ygyno.2010.10.004","article-title":"Conservative treatment of early endometrial cancer: preliminary results of a pilot study","volume":"120","author":"Laurelli","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2020.08.032_bib14","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/1471-0528.12499","article-title":"Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial","volume":"121","author":"Orbo","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2020.08.032_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ygyno.2013.11.007","article-title":"Impact of obesity on the results of fertility-sparing management for atypical hyperplasia and grade 1 endometrial cancer","volume":"133","author":"Gonthier","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2020.08.032_bib16","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00404-013-2826-8","article-title":"A\u00a0prospective study of fertility-sparing treatment with megestrol acetate following hysteroscopic curettage for well-differentiated endometrioid carcinoma and atypical hyperplasia in young women","volume":"288","author":"Shan","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2020.08.032_bib17","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/IGC.0000000000000467","article-title":"Fertility-sparing treatment of early endometrial cancer and complex atypical hyperplasia in young women of childbearing potential","volume":"25","author":"Pronin","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2020.08.032_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ygyno.2017.04.006","article-title":"Nonoperative management of atypical endometrial hyperplasia and grade 1 endometrial cancer with the levonorgestrel intrauterine device in medically ill post-menopausal women","volume":"146","author":"Baker","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2020.08.032_bib19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.ajog.2020.08.032_bib20","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1200\/JCO.2014.58.3401","article-title":"Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma","volume":"33","author":"Slomovitz","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2020.08.032_bib21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1158\/1940-6207.CAPR-17-0398","article-title":"Prospective randomized biomarker study of metformin and lifestyle intervention for prevention in obese women at increased risk for endometrial cancer","volume":"11","author":"Yates","year":"2018","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.ajog.2020.08.032_bib22","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.4161\/cbt.8.22.9740","article-title":"Molecular clustering of endometrial carcinoma based on estrogen-induced gene expression","volume":"8","author":"Westin","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.ajog.2020.08.032_bib23","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1158\/1940-6207.CAPR-13-0020","article-title":"Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus depo-provera for prevention of endometrial cancer in women with Lynch syndrome","volume":"6","author":"Lu","year":"2013","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.ajog.2020.08.032_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju245","article-title":"Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma","volume":"106","author":"Liu","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2020.08.032_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/onc.2008.363","article-title":"Beta-catenin mediates glandular formation and dysregulation of beta-catenin induces hyperplasia formation in the murine uterus","volume":"28","author":"Jeong","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.ajog.2020.08.032_bib26","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/carcin\/bgy079","article-title":"Oestrogen fuels the growth of endometrial hyperplastic lesions initiated by overactive Wnt\/\u03b2-catenin signalling","volume":"39","author":"Goad","year":"2018","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ajog.2020.08.032_bib27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/sim.4780140404","article-title":"Bayesian sequential monitoring designs for single-arm clinical trials with multiple outcomes","volume":"14","author":"Thall","year":"1995","journal-title":"Stat Med"},{"key":"10.1016\/j.ajog.2020.08.032_bib28","doi-asserted-by":"crossref","first-page":"431950","DOI":"10.1155\/2010\/431950","article-title":"Successful treatment of early endometrial carcinoma by local delivery of levonorgestrel: a case report","volume":"2010","author":"Wildemeersch","year":"2010","journal-title":"Obstet Gynecol Int"},{"key":"10.1016\/j.ajog.2020.08.032_bib29","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/cncr.21649","article-title":"Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study","volume":"106","author":"Zaino","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2020.08.032_bib30","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/cncr.21650","article-title":"Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study","volume":"106","author":"Trimble","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2020.08.032_bib31","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/AOG.0b013e31828cb563","article-title":"Prediction of regression and relapse of endometrial hyperplasia with conservative therapy","volume":"121","author":"Gallos","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.032_bib32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.gore.2018.09.001","article-title":"Conservative management of endometrial hyperplasia or carcinoma with the levonorgestrel intrauterine system may be less effective in morbidly obese patients","volume":"26","author":"Graul","year":"2018","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.ajog.2020.08.032_bib33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/AOG.0000000000002390","article-title":"Treatment of low-risk endometrial cancer and complex atypical hyperplasia With the levonorgestrel-releasing intrauterine device","volume":"131","author":"Pal","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.08.032_bib34","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1074\/mcp.RA119.001506","article-title":"Phosphoproteome analysis reveals estrogen-ER pathway as a modulator of mTOR activity via DEPTOR","volume":"18","author":"Cuesta","year":"2019","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.ajog.2020.08.032_bib35","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.3892\/ol.2017.6877","article-title":"Role of metformin in inhibiting estrogen-induced proliferation and regulating ER\u03b1 and ER\u03b2 expression in human endometrial cancer cells","volume":"14","author":"Zhang","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ajog.2020.08.032_bib36","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1349-7006.2010.01829.x","article-title":"Inhibiting the PI3K\/Akt pathway reversed progestin resistance in endometrial cancer","volume":"102","author":"Gu","year":"2011","journal-title":"Cancer Sci"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937820308619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937820308619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:11:23Z","timestamp":1778638283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937820308619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0002937820308619"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2020.08.032","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2020.08.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}